Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 3546 entries
View as:

Study to Evaluate Product Duration of Use Experience With Alclometasone Dipropionate Cream

Phase: N/A Priority: Normal
NCT ID: NCT02075632 Org: User:
Start: 09/30/06 End: 11/30/06 Due: 11/30/07

28-day Repeat Dose and Drug Interaction Study With Orvepitant (GW823296)

Phase: N/A Priority: Normal
NCT ID: NCT00511654 Org: User:
Start: 06/12/07 End: 01/11/08 Due: 01/11/09

Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers

Phase: N/A Priority: Normal
NCT ID: NCT00550420 Org: User:
Start: 10/01/07 End: 02/12/09 Due: 02/12/10

Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.

Phase: N/A Priority: Normal
NCT ID: NCT00370396 Org: User:
Start: 09/25/06 End: 11/06/07 Due: 11/06/08

Effects Of Repeat Inhaled Doses Of GW597901X On Patient Safety And Lung Function In Asthmatic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00354042 Org: User:
Start: 08/31/04 End: - Due: -

A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)

Phase: N/A Priority: Normal
NCT ID: NCT06537414 Org: User:
Start: 11/11/24 End: 07/28/27 Due: 07/28/28

A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT06113198 Org: User:
Start: 11/10/23 End: 10/30/26 Due: 10/30/27

Neutrophil Imaging in Healthy Subjects Following Lipopolysaccharide or Saline Challenge and in Subjects With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT02551614 Org: User:
Start: 03/17/15 End: 05/24/16 Due: 05/24/17

A Mechanistic Study of GSK3228836 With Fine Needle Aspiration (FNA) in Participants With Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT04544956 Org: User:
Start: 10/06/20 End: 11/30/23 Due: 11/30/24

The Safety, Tolerability And Metabolism Of GSK221149A, In Pregnant Women (30-36 Weeks), In Pre-Term Labor

Phase: N/A Priority: Normal
NCT ID: NCT00404768 Org: User:
Start: 10/12/07 End: 07/07/11 Due: 07/07/12

A Placebo-controlled Study to Investigate the Safety, and Pharmacokinetics of Oral GSK626616AC in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00443170 Org: User:
Start: 11/30/06 End: - Due: -

A Phase 3 Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (LATITUDE-TIMI 60)

Phase: N/A Priority: Normal
NCT ID: NCT02145468 Org: User:
Start: 06/03/14 End: 12/14/15 Due: 12/14/16

Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00379730 Org: User:
Start: 03/21/06 End: 05/03/07 Due: 05/03/08

Single Dose Escalation First Time in Human PK Study

Phase: N/A Priority: Normal
NCT ID: NCT00828867 Org: User:
Start: 11/14/08 End: 12/07/09 Due: 12/07/10

NSCLC Burden of Illness Study

Phase: N/A Priority: Normal
NCT ID: NCT01772225 Org: User:
Start: 09/30/13 End: 01/31/14 Due: 01/31/15

Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01165203 Org: User:
Start: 09/30/10 End: 05/14/13 Due: 05/14/14

BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115

Phase: N/A Priority: Normal
NCT ID: NCT01597622 Org: User:
Start: 06/11/12 End: 09/13/18 Due: 09/13/19

A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01101568 Org: User:
Start: 04/14/10 End: 06/24/10 Due: 06/24/11

Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting

Phase: N/A Priority: Normal
NCT ID: NCT00366834 Org: User:
Start: 07/31/06 End: 10/31/09 Due: 10/31/10

Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to MTX Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00611455 Org: User:
Start: 01/01/08 End: 07/15/13 Due: 07/15/14

REQUIP RLS Post Marketing Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT01327339 Org: User:
Start: 04/01/06 End: 11/30/09 Due: 11/30/10

A Phase I/II, a Single Arm, Open-label Study of Ofatumumab (GSK1841157) in Patients With Previously Treated Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01077622 Org: User:
Start: 09/01/09 End: 04/01/11 Due: 04/01/12

Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)

Phase: N/A Priority: Normal
NCT ID: NCT00424177 Org: User:
Start: 03/31/07 End: 11/30/08 Due: 11/30/09

Combination Of PAXIL Tablet And Benzodiazepines

Phase: N/A Priority: Normal
NCT ID: NCT00259883 Org: User:
Start: 06/30/05 End: 02/28/06 Due: 02/28/07

In Situ Caries of Fluoride Toothpastes

Phase: N/A Priority: Normal
NCT ID: NCT00708123 Org: User:
Start: 11/30/07 End: 04/30/08 Due: 04/30/09